| [1] Sekhon LH, Fehlings MG. Epidemioiogy,demographics,and pathophysiology of acute spinal cord injury. Spine. 2001; 26(24Suppl):S2-12.[2] Coleman WP, Geisler FH. Injury severity as primary predictor of outcome in acute spinal cord injury: retrospective results from a large multicenter clinical trial. Spine J. 2004;4(4): 373-378. [3] Schwab JM, Brechtel K, Mueller CA, et al. Experimental strategies to promote spinal cord regeneration-an integrative perspective. Prog Neurobiol. 2006;78(2):91-116.[4] Ito Y, Sugimoto Y, Tomioka M, et al. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury? Spine. 2009;34(20):2121-2124.[5] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.[6] Okita K, lehisaka T, Yamanaka S. Generation of gerraline-competent induced pluripelent stem cells. Nature. 2007;448(7151):313-317.[7] Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-872.[8] Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-1920.[9] Okita K, Ichisaka T, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26(1):101-106.[10] Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration. Science. 2008; 322(5903):945-949.[11] Woltjen K, Michael IP, Mohseni P, et al. piggybac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009;458(7239):766-770.[12] Wernig M, Meissner A, Cassady JP, et al. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell. 2008;2(1):10-12.[13] Kim JB, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature. 2008;454(7204):646-650.[14] Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency in adult neural stem cells. Cell. 2009;136(3):411-419.[15] Salewski RP, Eftekharpour E, Fehlings MG. Are Induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury? J Cell Physiol. 2010; 222(3): 515-521.[16] Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4(5):381-384.[17] Karumbayaram S, Novitch BG, Patterson M, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells. 2009; 27(4): 806-811.[18] Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Natl Acad Sci USA. 2008;105(15):5856-5861.[19] Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008; 321(5893): 1218-1221.[20] Hu BY, Zhang SC. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoe. 2009;4(9): 1295-1304.[21] Kimura H, Yeshikawa M, Matsuda R, et al. Transplantation of embryonic stem cell-derived neural stem cells for spinal cord injury in adult mice. Neurol Res. 2005;27(8):812-819.[22] Grinnemo KH, Kumagai-Braesch M, Mansson-Broberg A, et al. Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online. 2006;13(5):712-724.[23] Preynat-Seauve O, de Rham C, Tirefort D, et al. Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. J Cell Mol Med. 2009;13(9B):3556-3569.[24] Ao Q, Wang AJ, Chen GQ, et al. Combined transplantation of neural stem cells and elfactory ensheathing cells for the repair of spinal cord injuries. Med Hypotheses. 2007;69(6): 1234-1237.[25] Li J, Sun CR, Zhang H, et al. Induction of functional recovery by co-transplantation of neural stem cells and Schwann cells in a rat spinal cord contusion injury model. Biomed Environ Sci. 2007;20(3):242-249.[26] Isele NB, Lee HS, Landshamer S, et al. Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons. Neurochem Intl. 2007;50(1): 243-250.[27] Lu P, Jones LL, Tuszynski MH. Axon regeneration through scars and into sites of chronic spinal cord injury. Exp Neurol. 2007;203(1):8-21.[28] Richter MW, Roskams AJ. Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope? Exp Neurol. 2008;209(2):353-367.[29] Féron F, Perry C, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005;128(Pt 12):2951-2960.[30] O’Malley J, Woltjen K, Kaji K. New strategies to generate induced pluripotent stem cells. Curr Opin Biotechnol. 2009; 20(5):516-521.[31] Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;6:e1000029.[32] Habwe VQ. Posttransplantation quality of life: more than graft function. Am J Kidney Dis. 2006;47(4 Suppl 2):S98-110.[33] Yamanaka S. A fresh look at iPS cells. Cell. 2009;137(1): 13-17.[34] Ellis J, Bruneau BG, Kelle G, et al. Alternative induced pluripotent stem cell characterization criteria for in vitro applications. Cell Stem Cell. 2009;4(3):198-199.[35] Alper J. Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol. 2009;27(3):213-214. |
